Aging reshapes breast tissue, boosting cancer risk via epigenetic and immune shifts. Key insights for clinical practice.

A protein called Runx2 contributes to the abnormal activity of lung cells that drive pulmonary fibrosis, a new study shows.

MIAMI, FLORIDA / / February 21, 2025 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), or Telomir, a leader in age-reversal science, today announce ...

Researchers at Duke-NUS Medical School have identified YAP and TAZ proteins as key drivers of pulmonary fibrosis. Blocking ...

A discovery offers new hope in the battle against pulmonary fibrosis, a debilitating lung condition that progressively makes it harder for patients to breathe. Scientists have pinpointed proteins in ...

A discovery at Duke-NUS Medical School offers new hope in the battle against pulmonary fibrosis, a debilitating lung ...

CRISPR Technology Shows Promise in Removing Extra Chromosomes in Down SyndromeGene editing techniques may eventually allow ...

Decades ago, researchers showed that Down syndrome (also known as trisomy 21), was caused when individuals carried an extra ...

AP2A1 could serve as a biomarker for aging and a target for therapies aimed at slowing down or even reversing the aging ...

Researchers from the European Molecular Biology Laboratory have found that dextromethorphan, a common cough syrup ingredient, ...

A discovery at Duke-NUS Medical School offers new hope in the battle against pulmonary fibrosis, a debilitating lung condition that progressively makes it harder for patients to breathe. Scientists ...